Oncolytics Biotech, Inc. (ONCY)
0.98
+0.04
(+3.74%)
USD |
NASDAQ |
Dec 09, 16:00
0.98
0.00 (0.00%)
After-Hours: 18:20
Oncolytics Biotech Shareholders Equity (Quarterly): 0.0827M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 365.77M |
| Edesa Biotech, Inc. | 14.13M |
| Lexaria Bioscience Corp. | 2.990M |
| Xenon Pharmaceuticals, Inc. | 559.51M |
| ProMIS Neurosciences, Inc. | 9.187M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.82M |
| Total Liabilities (Quarterly) | 10.74M |
| Debt to Equity Ratio | 7.256 |
| Current Ratio | 1.836 |
| Net Debt Paydown Yield | 0.03% |